MAYO CLINIC
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Mayo Designed Soft Tissue Ultrasound-Detectable Marker
Not Applicable
Completed
- Conditions
- Ultrasound Therapy; ComplicationsBreast Neoplasm Female
- Interventions
- Device: Research Marker
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 8
- Registration Number
- NCT04674852
- Locations
- ๐บ๐ธ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration
Phase 1
Completed
- Conditions
- Hand InjuriesHand Injuries and DisordersInfectionHand Injury WristHand Arthritis
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT04673877
- Locations
- ๐บ๐ธ
Mayo Clinic in Arizona, Phoenix, Arizona, United States
Mediterranean Diet Post-liver Transplantation
Not Applicable
Recruiting
- Conditions
- Liver Transplantation
- Interventions
- Behavioral: Dietary Intervention
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 80
- Registration Number
- NCT04672863
- Locations
- ๐บ๐ธ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
Completed
- Conditions
- Clostridioides Difficile Infection
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2023-07-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT04668014
- Locations
- ๐บ๐ธ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Home Telemonitoring In Patients After Myocardial Infarction
Not Applicable
Completed
- Conditions
- Myocardial InfarctionHeart Attack
- Interventions
- Device: SmartHeart Device
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 195
- Registration Number
- NCT04664881
- Locations
- ๐บ๐ธ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Continuous Glucose Monitoring in Hospitalized Patients with Diabetes Mellitus
Not Applicable
Active, not recruiting
- Conditions
- Diabete Mellitus
- Interventions
- Device: Continuous Glucose Monitor (CGM)
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 150
- Registration Number
- NCT04653454
- Locations
- ๐บ๐ธ
Mayo Clinic in Florida, Jacksonville, Florida, United States
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Phase 4
Terminated
- Conditions
- Intractable EpilepsyMalignant GliomaSeizure DisorderWHO Grade 2 GliomaWHO Grade 3 Glioma
- Interventions
- Drug: Anticonvulsant AgentDrug: PerampanelOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 4
- Registration Number
- NCT04650204
- Locations
- ๐บ๐ธ
Mayo Clinic in Florida, Jacksonville, Florida, United States
Spasmodic Dysphonia Pain
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 32
- Registration Number
- NCT04648891
- Locations
- ๐บ๐ธ
Mayo Clinic in Arizona, Phoenix, Arizona, United States
Nitrates and IL-8 in Barrett's Esophagus
Terminated
- Conditions
- Esophageal AdenocarcinomaBarrett Esophagus
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2022-12-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 9
- Registration Number
- NCT04642690
- Locations
- ๐บ๐ธ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma
Phase 1
Recruiting
- Conditions
- Recurrent Hodgkin LymphomaRecurrent Non-Hodgkin LymphomaRecurrent Plasma Cell MyelomaRecurrent Histiocytic and Dendritic Cell NeoplasmRefractory Histiocytic and Dendritic Cell NeoplasmRefractory Hodgkin LymphomaRefractory Non-Hodgkin LymphomaRefractory Plasma Cell Myeloma
- Interventions
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 39
- Registration Number
- NCT04640779
- Locations
- ๐บ๐ธ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath